MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Burn Outcomes in Young Adult Burn Survivors

Completed

Conditions: Burns
Trauma

Interventions: Other: Questionnaire self report

First Posted Date: 2010-12-06

Last Posted Date: 2015-10-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 15

Registration Number: NCT01254357

Locations: 🇺🇸
Mass General Hospital, Boston, Massachusetts, United States
🇺🇸
Shriners Hospital for Children - Boston, Boston, Massachusetts, United States
🇺🇸
Shriners Hospital for Children - Galveston, Galveston, Texas, United States

and more 3 locations

Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders

Phase 2

Terminated

Conditions: Autism Spectrum Disorder (ASD)

Interventions: Drug: Omega-3 Fatty Acid

First Posted Date: 2010-11-25

Last Posted Date: 2025-03-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 7

Registration Number: NCT01248130

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

National Pregnancy Registry for Psychiatric Medications

Recruiting

Conditions: Pregnant Women
Psychotropic Drugs

First Posted Date: 2010-11-23

Last Posted Date: 2023-11-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5000

Registration Number: NCT01246765

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Phase 4

Terminated

Conditions: Presence of Heparin/Platelet Factor 4 Antibody
Coronary Artery Bypass Graft Surgery

Interventions: Drug: Argatroban and warfarin

First Posted Date: 2010-11-23

Last Posted Date: 2017-11-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 9

Registration Number: NCT01246011

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Temporal Intervention Trial of a CPR Video in the ICU

Not Applicable

Conditions: Admission to ICU

Interventions: Behavioral: video decision aid

First Posted Date: 2010-11-16

Last Posted Date: 2020-11-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT01241955

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Using Videos in Advance Care Planning for Patients With Advanced Cancer

Not Applicable

Completed

Conditions: Advanced Cancer

Interventions: Behavioral: video decision aid

First Posted Date: 2010-11-16

Last Posted Date: 2012-07-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 150

Registration Number: NCT01241929

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Prospective Randomized Trial of Static-Progressive Versus Dynamic Splinting for Post-Traumatic Elbow Stiffness

Not Applicable

Completed

Conditions: Post-traumatic Stiff Elbows

Interventions: Device: Static-Progressive Splint
Device: Dynamic Splint

First Posted Date: 2010-11-16

Last Posted Date: 2012-07-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 66

Registration Number: NCT01241916

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Pre-Hypertension
Hypertension

Interventions: Drug: Cholecalciferol

First Posted Date: 2010-11-15

Last Posted Date: 2017-03-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 534

Registration Number: NCT01240512

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States

Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma

Phase 2

Completed

Conditions: Marginal Zone Lymphoma
Small Lymphocytic Lymphoma
Follicular Lymphoma

Interventions: Drug: ofatumumab

First Posted Date: 2010-11-11

Last Posted Date: 2017-10-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 43

Registration Number: NCT01239394

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Culturally-focused Consultation for Asian Americans and Latino Americans

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Culturally focused psychiatric consultation

First Posted Date: 2010-11-11

Last Posted Date: 2014-10-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 122

Registration Number: NCT01239407

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy